- Home
- NVST vs MRUS Comparison
NVST vs MRUS Comparison
Compare NVST & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVST
- MRUS
- Stock Information
- Founded
- NVST 2018
- MRUS 2003
- Country
- NVST United States
- MRUS Netherlands
- Employees
- NVST N/A
- MRUS N/A
- Industry
- NVST Medical/Dental Instruments
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- NVST Health Care
- MRUS Health Care
- Exchange
- NVST Nasdaq
- MRUS Nasdaq
- Market Cap
- NVST 3.3B
- MRUS 2.7B
- IPO Year
- NVST 2019
- MRUS 2016
- Fundamental
- Price
- NVST $15.18
- MRUS $43.06
- Analyst Decision
- NVST Hold
- MRUS Strong Buy
- Analyst Count
- NVST 13
- MRUS 13
- Target Price
- NVST $20.54
- MRUS $86.85
- AVG Volume (30 Days)
- NVST 4.0M
- MRUS 872.0K
- Earning Date
- NVST 05-01-2025
- MRUS 05-07-2025
- Dividend Yield
- NVST N/A
- MRUS N/A
- EPS Growth
- NVST N/A
- MRUS N/A
- EPS
- NVST N/A
- MRUS N/A
- Revenue
- NVST $2,510,600,000.00
- MRUS $36,133,000.00
- Revenue This Year
- NVST $2.37
- MRUS $26.81
- Revenue Next Year
- NVST $3.11
- MRUS $23.85
- P/E Ratio
- NVST N/A
- MRUS N/A
- Revenue Growth
- NVST N/A
- MRUS N/A
- 52 Week Low
- NVST $14.22
- MRUS $33.19
- 52 Week High
- NVST $23.00
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- NVST 38.74
- MRUS 51.15
- Support Level
- NVST $14.22
- MRUS $33.19
- Resistance Level
- NVST $15.84
- MRUS $43.46
- Average True Range (ATR)
- NVST 0.96
- MRUS 3.53
- MACD
- NVST -0.02
- MRUS 0.34
- Stochastic Oscillator
- NVST 27.83
- MRUS 80.53
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.